Aav Vector Development for Lung Specific Gene Therapy

Trempe, James P.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project (R01)
• Project #: 1R01HL058347-01
• Application #: 2031548
• Study Section: Special Emphasis Panel (SRC (06))
• Project Start: 1996-09-30
• Project End: 2000-08-31
• Budget Start: 1996-09-30
• Budget End: 1997-08-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: University of Toledo
• Department: Biochemistry
• Type: Schools of Medicine
• DUNS #: 807418939
• City: Toledo
• State: OH
• Country: United States
• Zip Code: 43614

Publications

Jing, X J; Kalman-Maltese, V; Cao, X et al. (2001) Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus. Virology 291:140-51

Collaco, R F; Cao, X; Trempe, J P (1999) A helper virus-free packaging system for recombinant adeno-associated virus vectors. Gene 238:397-405

Chirico, J; Trempe, J P (1998) Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections. J Virol Methods 76:31-41